[Bevacizumab therapy for Poems syndrome].
Doffoel-Hantz
V
V
Jaccard
A
A
Sparsa
A
A
Girault
S
S
Bonnetblanc
J M
JM
Bordessoule
D
D
Bédane
C
C
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008875:Middle Aged; D016878:POEMS Syndrome / Q000188:drug therapy*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab